newsfilter
← Latest News
GlobeNewswire·

Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference

-Dr. Praveen Tipirneni, returns in full capacity as Chief Executive Officer from medical leave- WALTHAM, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ:MORF), a biotechnology company developing a